Kindstar Globalgene Technology, Inc.
Research Kindstar Globalgene Technology, Inc. (9960.HK) on Bullrun: market cap HKD 899.51M, dividend yield 10.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker9960.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 899.51M
- Dividend yield10.5%
- Financial periodFY2025
- RevenueCNY 933.57M
- Revenue growth0.6%
- Net income-CNY 58.74M
- Free cash flowCNY 43.60M
- Gross margin44.0%
Valuation Snapshot
latest market cap is HKD 899.51M; dividend yield is 10.5%.
Peer valuation comparison
Latest dividend yield is 10.5% versus a Healthcare sector median of 2.41% (335.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 933.57M | -CNY 58.74M | CNY 43.60M | 44.0% | n/a | CNY 382.19M | CNY 413.85M | CNY 2.73B |
| FY2024 | CNY 927.57M | -CNY 54.59M | -CNY 179.58M | 47.4% | -0.06 | CNY 381.57M | CNY 398.36M | CNY 2.78B |
| FY2023 | CNY 967.26M | CNY 41.29M | -CNY 189.65M | 46.6% | 0.04 | CNY 1.47B | CNY 194.29M | CNY 2.87B |
| FY2022 | CNY 1.39B | CNY 75.46M | -CNY 102.90M | 43.5% | 0.09 | CNY 680.36M | CNY 199.86M | CNY 2.83B |
| FY2021 | n/a | n/a | n/a | n/a | -2.93 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 899.51M | n/a | 10.5% | 0.1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.1 HKD, yield 10.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.02 CNY |
| FY2024 | 0.03 CNY |
About Kindstar Globalgene Technology, Inc.
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China and Mainland China. It operates through nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kindstar Globalgene Technology, Inc.'s market cap?
Kindstar Globalgene Technology, Inc.'s market capitalization is HKD 899.51M.
Does Kindstar Globalgene Technology, Inc. pay a dividend?
Kindstar Globalgene Technology, Inc. has a dividend yield of 10.5%.
What does Kindstar Globalgene Technology, Inc. do?
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China and Mainland China. It operates through nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases.